Aurobindo Pharma Ltd's net profit increased by 58 per cent at Rs 372 crore in the second quarter ended September 30, 2014 compared to Rs 230 crore in the year ago period.
The total revenue of the company too increased 50 per cent to Rs 2,,881 crore (Rs 1,913 cr) on higher generic sales.
"The September quarter performance has been satisfactory mainly on account of over all growth led by US generics," N Govindarajan, Managing Director of Aurobindo Pharma said in a release on Thursday.
Aurobindo's scrip ended flat at Rs 1001.90 on the Bombay Stock Exchange on Wednesday.